TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal

Chair, Professor Peter Schmid, FRCP, MD, PhD, Carlos H. Barrios, MD, Eva M. Ciruelos, MD, PhD, and Hope S. Rugo, MD, FASCO, discuss Breast Cancer in this CME/MOC activity titled “TROP2-Targeting ADCs as New Tools in the TNBC and HR+/HER2- Breast Cancer Treatment Arsenal: Advancing Patient-Centered Care to Make the Most of Modern Targeted Treatments.” For the full presentation, downloadable Practice Aids, slides, and complete CME/MOC information, and to apply for credit, please visit us at PeerView.com/ZDH865. CME/MOC credit will be available until December 15, 2023.